TNFSF4 and Hepatic fibrosis: We also identified the OX40 ligand (OX40L)-OX40 axis as a key immunoregulatory pathway in MASH, demonstrating that inhibition of the OX40L-OX40 signaling reverses hepatic fibrosis in established murine MASH.